| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Molecular Imaging |
1 From the Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, 13th St, Bldg 149, Rm 5408, Boston, MA 02129. Received May 28, 2003; revision requested August 7; revision received September 3; accepted October 14. Supported in part by National Institutes of Health grants P50-CA86355 and R24-CA92782. U.M. supported in part by an award from the Broad Medical Research Program of the Eli and Edythe L. Broad Foundation, Los Angeles, Calif. M.A.F. supported by a stipend from the Max Kade Foundation, New York. Address correspondence to U.M. (e-mail: mahmood@helix.mgh.harvard.edu).
PURPOSE: To construct and evaluate an interventional catheter-based imaging system for intravital monitoring of molecularly sensitive near-infrared fluorescent probes and optical marker genes.
MATERIALS AND METHODS: An imaging device that was based on a miniaturized fiberoptic sensor (MIFS) was built in which images created with a 2.7-F fiberoptic catheter were relayed through a dichroic mirror, through a bandpass filter, and on two independent cameras. This system permitted simultaneous recording of white-light and fluorescent images. Spatial resolution, spectral transmissions, and sensitivity were determined in vitro. In vivo testing was performed in nude mice bearing intraperitoneal tumors that express green fluorescent protein and in a mouse model of ovarian carcinoma with enzyme-activatable near-infrared probes sensitive to tumoral protease activity. Signal intensity on images of tumors and that on images of normal tissue were measured and compared with t test.
RESULTS: The catheter, which was advanced through an 18-gauge sheath, showed resolution of 7 line pairs per millimeter and detection limit for fluorochrome Cy5.5 of 1–10 pmol. Detection of endogeneous green fluorescent protein gene expression was feasible in tumor nodules smaller than 1 mm in diameter (mean tumor signal intensity, 153.26 ± 26.45 [SD], compared with that of adjacent nontumoral tissue of 36.73 ± 11.69; P < .008). Similarly, activation of the near-infrared probe by tumoral proteases could be detected in peritoneal tumor seeds of ovarian cancer model with mean tumor signal intensity of 246.33 ± 7.77 compared with that of adjacent nontumoral tissue of 41.56 ± 18.64 (P < .001). Mean contrast-to-noise ratio in the near-infrared channel exceeded white-light contrast-to-noise ratio by a factor of 6.7 (P < .02).
CONCLUSION: With this system, in vivo MIFS imaging of gene expression, enzyme activity, and potentially other molecular events is feasible, through direct interventional access to several organs and body cavities and potentially through transvascular approaches.
© RSNA, 2004
Index terms: Animals • Catheters and catheterization, technology • Enzymes • Experimental study • Genes and genetics
Related Article
Radiology 2004 231: 609-610.
This article has been cited by other articles:
|
|
 |
|
  R. A. Sheth, J. M. Tam, M. A. Maricevich, L. Josephson, and U. Mahmood Quantitative Endovascular Fluorescence-based Molecular Imaging through Blood of Arterial Wall Inflammation Radiology, June 1, 2009; 251(3): 813 - 821. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Upadhyay, R. A. Sheth, R. Weissleder, and U. Mahmood Quantitative Real-time Catheter-based Fluorescence Molecular Imaging in Mice Radiology, November 1, 2007; 245(2): 523 - 531. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. T. Heverhagen Smart Near-Infrared Imaging Probes--A Quantum Leap for Early Detection of Colorectal Cancer? Radiology, July 1, 2007; 244(1): 1 - 2. [Full Text] [PDF]
|
|
|
|
|
|
H. Alencar, M. A. Funovics, J. Figueiredo, H. Sawaya, R. Weissleder, and U. Mahmood Colonic Adenocarcinomas: Near-Infrared Microcatheter Imaging of Smart Probes for Early Detection--Study in Mice Radiology, July 1, 2007; 244(1): 232 - 238. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. R. Kim, A. Yudina, J. Figueiredo, W. Reichardt, D. Hu-Lowe, A. Petrovsky, H. W. Kang, D. Torres, U. Mahmood, R. Weissleder, et al. Detection of Early Antiangiogenic Effects in Human Colon Adenocarcinoma Xenografts: In vivo Changes of Tumor Blood Volume in Response to Experimental VEGFR Tyrosine Kinase Inhibitor Cancer Res., October 15, 2005; 65(20): 9253 - 9260. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. O. Bonow Molecular Beacons Illuminate Subcellular Events Circulation, April 12, 2005; 111(14): 1730 - 1732. [Full Text] [PDF]
|
|
|
|
 |
|
 F. A. Jaffer and R. Weissleder Molecular Imaging in the Clinical Arena JAMA, February 16, 2005; 293(7): 855 - 862. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Jiang, E. S. Olson, Q. T. Nguyen, M. Roy, P. A. Jennings, and R. Y. Tsien Tumor imaging by means of proteolytic activation of cell-penetrating peptides PNAS, December 21, 2004; 101(51): 17867 - 17872. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Hoffman Can Optical Molecular Imaging Techniques with Catheter-based Approaches Be Used for Disease Detection? Radiology, June 1, 2004; 231(3): 609 - 610. [Full Text] [PDF]
|
|
